Natixis Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12,249	Closed	-$274K	–	1626
2024 Q2	$274K	Sell	12,249 -199	-2%	-$4.45K	﹤0.01%	1539
2024 Q1	$342K	Buy	+12,448	New	+$342K	﹤0.01%	1458